Cryo-Cell International Gross Profit

Cryo-Cell International (CCEL) currently reports a gross profit of $24M as of May 2026. That compares with $24M in the prior-year period — down 1.3% year over year. That is below the Healthcare sector average of $67B. Use the charts on this page to explore Cryo-Cell International's gross profit history and peer comparisons.

Cryo-Cell International's gross profit decreased from $24M to $24M — a 1.3% year-over-year decrease (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cryo-Cell International's gross profit of $24M is lower than the Healthcare sector average of $67B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Cryo-Cell International reported $24M in gross profit as of May 2026. That compares with $24M in the prior-year period — down 1.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $24M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $67B. From there, open related valuation or income-statement pages for Cryo-Cell International, and consider following CCEL for alerts when major investors trade the stock.